News / Taiwan / cnyes
Kikkoman Pivots to Biotech Innovation, Says Executive Mogi
Consumer Non-Durables · Food: Major Diversified · cnyes · 2026-09-03
1216
Kikkoman is expanding its focus beyond traditional soy sauce into biotechnology, including enzymes and health foods, while strengthening its long-term partnership with Uni-President.
What Happened
Strategic Transformation: Kikkoman executive Osamu Mogi highlighted the company's commitment to advancing its biotechnology business, focusing on enzymes, koji, and health supplements to modernize its traditional operations.
Partnership Success: The long-standing joint venture between Kikkoman and Uni-President, established in 1990, serves as a cornerstone for the company's expansion strategy across Asia and remains a key distribution channel.
Financial Performance: The joint venture, Tong Wan, has demonstrated consistent growth, reporting 2025 revenue of 1.137 billion TWD and a net profit of 76.03 million TWD, reflecting strong market penetration.
Global Footprint: Kikkoman continues to thrive in international markets, particularly in North America, where its products have successfully transitioned from niche Japanese ingredients to essential household staples.